44 related articles for article (PubMed ID: 31517830)
1. Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China.
Zhao J; Guo Z; Wang Q; Si T; Pei S; Wang C; Qu H; Zhong J; Ma Y; Nie C; Zhang D
Infect Agent Cancer; 2017; 12():8. PubMed ID: 28138337
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and genotype distribution of human papillomaviruses among women in Taizhou, China.
Jin R; Qian H; Zhang Y; Yuan D; Bao J; Zhou H; Chen M; Huang J; Yu H
Medicine (Baltimore); 2019 Sep; 98(39):e17293. PubMed ID: 31574850
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and accuracy of cervical cancer screening with a high-risk HPV genotyping assay vs a nongenotyping assay in China: an observational cohort study.
Dong B; Chen L; Lin W; Su Y; Mao X; Pan D; Ruan G; Xue H; Kang Y; Sun P
Cancer Cell Int; 2020; 20():421. PubMed ID: 32868973
[TBL] [Abstract][Full Text] [Related]
4. Seven years prevalence and distribution of high and low risk HPV genotypes in women living in the metropolitan area of Naples.
Martora F; Della Pepa ME; Grimaldi E; Franci G; Folliero V; Petrillo A; Schettino MT; De Franciscis P; Galdiero M; Galdiero M
Cancer Epidemiol; 2019 Dec; 63():101625. PubMed ID: 31704648
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of human papillomaviruses distribution in Guizhou Province, China.
Chen Z; Li Q; Huang Q; Liu H; Jiang H; Chen Z; An Z; Luo Q
Virol J; 2019 Oct; 16(1):123. PubMed ID: 31665045
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccine against cervical cancer: Opportunity and challenge.
Wang R; Pan W; Jin L; Huang W; Li Y; Wu D; Gao C; Ma D; Liao S
Cancer Lett; 2020 Feb; 471():88-102. PubMed ID: 31812696
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human papillomavirus genotypes and their coverage in vaccine delivered to Ethiopian women.
Abate A; Munshea A; Nibret E; Alemayehu DH; Alemu A; Abdissa A; Mihret A; Abebe M; Mulu A
Sci Rep; 2024 Apr; 14(1):7976. PubMed ID: 38575600
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Dynamics of Human Papillomavirus and Diagnostic Discrepancies in Cervical Pathology: A Single Center Experience.
Zamurovic M; Tomic A; Pikula A; Simanic S; Knezevic A; Jankovic M; Lackovic M; Djakovic E; Rovcanin M
Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132198
[TBL] [Abstract][Full Text] [Related]
9. Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening.
Cenci M; Rossi F; Pisani T
In Vivo; 2023; 37(5):2161-2165. PubMed ID: 37652482
[TBL] [Abstract][Full Text] [Related]
10. Changes in High-Risk HPV Infection Prevalence and Associated Factors in Selected Rural Areas of China: A Multicenter Population-Based Study.
Yu YQ; Jiang MY; Dang L; Feng RM; Bangura MS; Chen W; Qiao YL
Front Med (Lausanne); 2022; 9():911367. PubMed ID: 35903319
[TBL] [Abstract][Full Text] [Related]
11. Distribution of human papillomavirus genotypes in suspected women cytological specimens from Tehran, Iran.
Tabibzadeh A; Panahi M; Bouzari B; Haghi Ashtiani MT; Zamani F; Teimoori Arzati H; Karbalaie Niya MH
Iran J Microbiol; 2022 Feb; 14(1):112-118. PubMed ID: 35664716
[TBL] [Abstract][Full Text] [Related]
12. Genotype-specific Distribution and Change of High-risk Human Papillomavirus Infection and the Association with Cervical Progression Risk in Women with Normal Pathology and Abnormal Cytology in a Population-based Cohort Study in China.
Jia H; Ding L; Han Y; Lyu Y; Hao M; Tian Z; Wang J
J Cancer; 2021; 12(14):4379-4388. PubMed ID: 34093838
[No Abstract] [Full Text] [Related]
13. Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia.
Xia C; Li S; Long T; Chen Z; Chan PKS; Boon SS
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070706
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of carcinogenic HPV genotypes in North China Plain and the association with cervical lesions.
Liu L; Wang D; Dong H; Jin C; Jiang L; Song H; Jin C; Wang T; Shi C; Yang L; Wang Y
Medicine (Baltimore); 2019 Sep; 98(37):e17087. PubMed ID: 31517830
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
16. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
17. The prevalence, genotype distribution of human papillomavirus and cervical cytology in Wenzhou, China: a retrospective research of 7391 cases.
Lin Q; Lin X; Zhuang X; Tang Y; Zhao Z
Diagn Cytopathol; 2021 Feb; 49(2):211-218. PubMed ID: 32965784
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus Genotype Distribution among Thai Women with High-Grade Cervical Intraepithelial Lesions and Invasive Cervical Cancer: a Literature Review.
Kietpeerakool C; Kleebkaow P; Srisomboon J
Asian Pac J Cancer Prev; 2015; 16(13):5153-8. PubMed ID: 26225645
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus testing and genotyping in cervical screening.
Rebolj M; Lynge E; Bonde J
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1023-31. PubMed ID: 21806326
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
